Effectiveness and cost-effectiveness of a new botulinum toxin treatment for benign essential blepharospasm

被引：0
|
作者：
Chierigo, Alberto [1 ]
Del Noce, Chiara [1 ]
Vagge, Aldo [1 ]
Traverso, Carlo [1 ]
机构：
[1] Univ Genoa, Ophthalmol, Genoa, Liguria, Italy
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TREATMENT OF BLEPHAROSPASM WITH BOTULINUM TOXIN
    TSOY, EA
    BUCKLEY, EG
    DUTTON, JJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1985, 99 (02) : 176 - 179
  • [42] Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment
    Yuka Hosotani
    Norihiko Yokoi
    Mana Okamoto
    Hiroto Ishikawa
    Aoi Komuro
    Hiroaki Kato
    Osamu Mimura
    Fumi Gomi
    Japanese Journal of Ophthalmology, 2020, 64 : 45 - 53
  • [43] Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment
    Hosotani, Yuka
    Yokoi, Norihiko
    Okamoto, Mana
    Ishikawa, Hiroto
    Komuro, Aoi
    Kato, Hiroaki
    Mimura, Osamu
    Gomi, Fumi
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2020, 64 (01) : 45 - 53
  • [44] Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm
    Cannon, Paul S.
    MacKenzie, Kenneth R.
    Cook, Anne E.
    Leatherbarrow, Brian
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 (07): : 688 - 691
  • [45] Cost-Effectiveness of Botulinum Toxin A Versus Anticholinergic Medications for Idiopathic Urge Incontinence
    Wu, Jennifer M.
    Siddiqui, Nazema Y.
    Amundsen, Cindy L.
    Myers, Evan R.
    Havrilesky, Laura J.
    Viscoll, Anthony G.
    JOURNAL OF UROLOGY, 2009, 181 (05): : 2181 - 2186
  • [46] 12-year effectiveness and safety of botulinum toxin type A for the treatment of blepharospasm and hemifacial spasm
    Colorado-Ochoa, Hector J.
    Tenorio-Gonzalez, Victoria G.
    REVISTA MEXICANA DE NEUROCIENCIA, 2024, 25 (04): : 109 - 114
  • [47] Cost-effectiveness of Xeomin® in the management of cervical dystonia and blepharospasm
    Chadda, Shkun
    Tilden, Dominic
    Jones, David
    Hawthorne, Maurice
    Wolf, Tilo
    Sykes, David
    EJHP PRACTICE, 2009, 15 (06): : 38 - 46
  • [48] THE COST-EFFECTIVENESS OF XEOMIN® IN CERVICAL DYSTONIA AND BLEPHAROSPASM IN SWEDEN
    Sykes, D.
    Egler, M.
    VALUE IN HEALTH, 2010, 13 (03) : A139 - A139
  • [49] Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial (vol 17, 129, 2016)
    Wickwar, Sadie
    McBain, Hayley
    Newman, Stanton P.
    Hirani, Shashivadan P.
    Hurt, Catherine
    Dunlop, Nicola
    Flood, Chris
    Ezra, Daniel G.
    TRIALS, 2016, 17
  • [50] TREATMENT OF ESSENTIAL BLEPHAROSPASM, HEMIFACIAL SPASM, AND MEIGS SYNDROME WITH BOTULINUM TOXIN
    BUCKLEY, EG
    ANNALS OF NEUROLOGY, 1986, 20 (01) : 121 - 121
12345